Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
85.85
+4.24 (5.20%)
Aug 13, 2025, 4:00 PM - Market closed
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Product Revenues | 3.96B | 3.81B | 3.62B | 3.46B | 3.28B | 3.20B | 3.17B | 3.07B | ||||||||||||||||||||
| Net Product Revenues Growth | 20.80% | 19.03% | 14.33% | 12.83% | 9.47% | 12.97% | 15.23% | 16.61% | ||||||||||||||||||||
| Royalties | 597.91M | 583.99M | 579.36M | 569.68M | 543.63M | 534.04M | 523.48M | 506.35M | ||||||||||||||||||||
| Royalties Growth | 9.98% | 9.35% | 10.67% | 12.51% | 11.90% | 12.25% | 8.44% | -1.69% | ||||||||||||||||||||
| Milestone and Contracts | 27.50M | - | - | 27.50M | - | 39.50M | 167.00M | 170.00M | - | - | 215.00M | - | 220.00M | 100.00M | - | - | - | - | - | |||||||||
| Milestone and Contracts Growth | -83.82% | - | - | -87.21% | - | -82.05% | 67.00% | -17.07% | - | - | -14.00% | - | -5.38% | -58.76% | - | - | - | - | - | |||||||||
| Other | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 203.00K | 178.00K |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and Development | 1.97B | 2.61B | 2.61B | 2.59B | 2.39B | 1.65B | 1.63B | 1.68B | ||||||||||||||||||||
| Research and Development Growth | -17.44% | 58.46% | 60.17% | 53.48% | 41.06% | 0.67% | 2.63% | 8.16% | ||||||||||||||||||||
| Selling, General, and Administrative | 1.29B | 1.27B | 1.24B | 1.21B | 1.17B | 1.15B | 1.16B | 1.14B | ||||||||||||||||||||
| Selling, General, and Administrative Growth | 10.67% | 10.62% | 6.96% | 6.06% | 2.56% | 3.41% | 15.88% | 19.33% | ||||||||||||||||||||
| Loss on Change in Fair Value of Acquisition-Related Contingent Consideration | 53.70M | 31.83M | 19.80M | 38.91M | 15.07M | 22.55M | 29.20M | 38.49M | ||||||||||||||||||||
| Loss on Change in Fair Value of Acquisition-Related Contingent Consideration Growth | 256.35% | 41.16% | -32.19% | 1.08% | -11.48% | 88.50% | 140.37% | - | ||||||||||||||||||||
| Loss Under Collaboration Agreements | - | - | - | - | - | 2.38M | 2.05M | -1.94M | -1.22M | 1.87M | 7.97M | 16.60M | 23.98M | - | - | - | - | - | - | - | - | - | ||||||
| Loss Under Collaboration Agreements Growth | - | - | - | - | - | 27.45% | -74.35% | - | - | -94.02% | -78.46% | -60.39% | -49.78% | - | - | - | - | - | - | - | - | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.